Eoux
NDC Package 66854-009-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Eoux is a medication designed for use in armpit areas as may cause irritation in the area of application by the sensitivity of the user. Marketed by Spai Sons Pharmaceutical International Cosmetics, this product is identified by NDC 66854-009 and is authorized under FDA application part350.

Identification & Billing

NDC Package Code
66854-009-01
Package Description
90 mL in 1 JAR
Product Code
66854-009
11-Digit Billing Format
66854000901

Clinical Specifications

Proprietary Name
Eoux Deodorant
Dosage Form
-
Usage Information
This product is designed for use in armpit areas as may cause irritation in the area of application by the sensitivity of the user.

Regulatory & Marketing

Labeler Name
Spai Sons Pharmaceutical International Cosmetics
FDA Application #
part350
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
05-31-2012
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66854-009-01 identifies a specific commercial package of 90 ml in 1 jar of Eoux Deodorant, labeled by Spai Sons Pharmaceutical International Cosmetics. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Spai Sons Pharmaceutical International Cosmetics on May 31, 2012. The current certification is valid through December 31, 2017.

How is this Spai Sons Pharmaceutical International Cosmetics product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66854000901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66854-009-01
11-Digit CMS (5-4-2)
66854-0009-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.